NNCSF Stock: Nanosonics Limited Stock Price, Analysis & Insights
Get live NNCSF stock price $2.30, comprehensive Nanosonics Limited stock analysis, charts, news, and expert forecast. Real-time NNCSF stock data and investment insights.
Loading chart data...
Nanosonics Limited (NNCSF) Overview
Nanosonics Limited (NNCSF) is a publicly traded company in the Healthcare sector , specifically within the Medical - Instruments & Supplies industry . As of the latest trading session, NNCSF trades at $2.30 with a market capitalization of 687.28M . Over the past 52 weeks, NNCSF has traded between $2.01 and $3.06 , with the current price positioned at approximately 28% of this range . The stock ...
Key Takeaways
- Operates in the Healthcare sector (Medical - Instruments & Supplies)
- Market cap: 687.28M
- Current price: $2.30
- 52-week range: $2.01 - $3.06
- P/E ratio: 46.00
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Nanosonics Limited, in conjunction with its subsidiaries, functions as an infection prevention enterprise, serving both Australian and international markets. The company's core activities involve the production and supply of the trophon ultrasound pr...
Company Information
- CEO
- Michael C. Kavanagh
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 466
Contact Information
- Address
- Building A
- Country
- AU
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 46.0)
✓ Higher growth potential with elevated volatility (Beta: 1.21)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Nanosonics Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Nanosonics Limited
- ⚠Investors should consider how Nanosonics Limited fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 46.0) requires strong growth to justify
Market Cap
687.28M
P/E Ratio (TTM)
46.00
Beta
1.21
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare NNCSF with peer companies:
- Price
- $2.97
- Market cap
- 807.58M
- Price
- $34.99
- Market cap
- 754.37M
- Price
- $0.23
- Market cap
- 1.03B
- Price
- $2.55
- Market cap
- 188.41M
- Price
- $2.31
- Market cap
- 906.63M
- Price
- $3.76
- Market cap
- 1.13B
- Price
- $8.56
- Market cap
- 702.61M
- Price
- $7.61
- Market cap
- 803.25M
- Price
- $0.82
- Market cap
- 1.64B
- Price
- $17.25
- Market cap
- 4.20B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.